Cardiovascular diseases (CVDs) are the leading cause of death and disability in India.
Moreover, mortality following an acute myocardial infarction is high, which may be due to …

Objective In patients with newly diagnosed atrial fibrillation (AF), do baseline risk factors and
stroke prevention strategies account for the geographically diverse outcomes. Design Global …

Abstract Background The Global Anticoagulant Registry in the FIELD–Atrial Fibrillation
(GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing …

Vitamin K antagonist (VKA) therapy for stroke prevention in atrial fibrillation (AF) requires
monitoring of the international normalized ratio (INR). We evaluated the agreement between …

Despite numerous improvements in the management of acute coronary syndrome (ACS), it
is a major cause of mortality in India. Lipids play a critical role in pathogenesis of ACS and …

Background Familial hypercholesterolemia (FH), an autosomal codominant disorder
characterized by very high low-density lipoprotein cholesterol, is strongly associated with …

Objective While greater body mass index (BMI) is associated with increased risk of
developing atrial fibrillation (AF), the impact of BMI on outcomes in newly diagnosed AF is …

At 75 years of independence, India is now among the fastest-growing and robust economies
in the world. The country has also made enormous progress in the health sector. Life …

Purpose: Little is known about current pre-hospital management in acute coronary
syndromes (ACS) patients in Asia. In this study we describe baseline pre-hospital …

Background The aim of study was to evaluate effect of Remogliflozin in T2DM with HF with
reduced ejection fraction (HFrEF) patients as compared to Empagliflozin using NT-proBNP …